Your browser is no longer supported. Please, upgrade your browser.
ICUI [NASD]
ICU Medical, Inc.
Index- P/E58.06 EPS (ttm)3.78 Insider Own1.60% Shs Outstand20.95M Perf Week0.18%
Market Cap4.70B Forward P/E30.67 EPS next Y7.16 Insider Trans-34.21% Shs Float19.61M Perf Month-0.99%
Income81.40M PEG3.63 EPS next Q1.51 Inst Own95.10% Short Float1.41% Perf Quarter18.24%
Sales1.27B P/S3.72 EPS this Y242.00% Inst Trans0.57% Short Ratio2.13 Perf Half Y20.24%
Book/sh69.32 P/B3.17 EPS next Y4.03% ROA4.60% Target Price237.00 Perf Year7.62%
Cash/sh16.96 P/C12.94 EPS next 5Y16.00% ROE5.80% 52W Range158.01 - 236.51 Perf YTD2.35%
Dividend- P/FCF44.09 EPS past 5Y22.70% ROI6.80% 52W High-7.17% Beta0.66
Dividend %- Quick Ratio3.10 Sales past 5Y32.60% Gross Margin36.00% 52W Low38.94% ATR5.90
Employees8000 Current Ratio4.90 Sales Q/Q3.60% Oper. Margin7.00% RSI (14)58.09 Volatility2.76% 2.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-6.20% Profit Margin6.40% Rel Volume0.48 Prev Close217.01
ShortableYes LT Debt/Eq0.00 EarningsFeb 25 AMC Payout0.00% Avg Volume129.47K Price219.54
Recom2.00 SMA203.53% SMA503.24% SMA20012.79% Volume61,589 Change1.17%
Mar-31-20Upgrade CJS Securities Market Perform → Market Outperform
Mar-18-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $206
Aug-08-19Downgrade Raymond James Strong Buy → Outperform
Oct-17-17Initiated KeyBanc Capital Mkts Sector Weight
Jun-20-17Downgrade Sidoti Buy → Neutral
Mar-11-16Initiated Gabelli & Co Buy $128
Nov-06-15Reiterated ROTH Capital Buy $124 → $130
Aug-11-15Reiterated ROTH Capital Buy $102 → $124
May-06-15Reiterated ROTH Capital Buy $96 → $102
Feb-10-15Reiterated ROTH Capital Buy $82 → $96
Nov-11-14Upgrade ROTH Capital Neutral → Buy $56 → $82
May-09-13Downgrade The Benchmark Company Buy → Hold
Sep-27-12Reiterated The Benchmark Company Buy $60 → $69
Apr-12-12Initiated The Benchmark Company Buy $60
Sep-26-11Reiterated Ticonderoga Buy $52 → $49
Oct-29-09Initiated C.K. Cooper Buy $45
Oct-08-09Initiated Roth Capital Hold $40
Mar-05-09Initiated Northland Securities Outperform
May-02-08Initiated Jesup & Lamont Buy $35
Mar-26-08Initiated Soleil Buy
Feb-24-21 08:30AM  
Feb-18-21 04:00AM  
Feb-04-21 08:00AM  
Feb-02-21 08:15AM  
Jan-13-21 02:23AM  
Jan-05-21 07:30AM  
Dec-22-20 10:21AM  
Dec-20-20 05:30PM  
Dec-08-20 02:10AM  
Nov-08-20 08:13AM  
Nov-06-20 02:01AM  
Nov-05-20 07:20PM  
04:05PM  
02:30PM  
Nov-02-20 09:44AM  
Oct-15-20 07:30AM  
Oct-07-20 08:51AM  
Sep-14-20 10:53PM  
Sep-11-20 09:36AM  
Sep-08-20 07:30AM  
Aug-19-20 01:15PM  
Aug-12-20 08:30AM  
Aug-10-20 09:00PM  
04:05PM  
04:00PM  
Aug-07-20 08:46AM  
Aug-03-20 12:31PM  
Jul-27-20 11:23AM  
Jul-20-20 12:14PM  
Jul-15-20 07:30AM  
Jun-17-20 11:35AM  
Jun-16-20 04:18PM  
Jun-15-20 09:31AM  
Jun-10-20 01:21PM  
Jun-08-20 05:56PM  
12:53PM  
Jun-05-20 08:44AM  
Jun-04-20 11:18AM  
Jun-03-20 04:21PM  
Jun-02-20 03:05PM  
May-28-20 04:53PM  
03:58PM  
01:40PM  
May-27-20 07:25PM  
06:30PM  
08:18AM  
May-25-20 03:00PM  
May-22-20 06:24PM  
May-21-20 04:20PM  
May-20-20 01:19PM  
May-19-20 07:00PM  
05:00PM  
02:54PM  
May-15-20 03:49PM  
11:42AM  
May-14-20 02:45PM  
May-08-20 02:30PM  
12:17PM  
04:46AM  
May-07-20 04:05PM  
Apr-30-20 12:33PM  
Apr-20-20 09:14AM  
07:30AM  
Apr-09-20 08:27AM  
Apr-02-20 01:00PM  
Apr-01-20 09:27AM  
Mar-27-20 02:53PM  
Mar-19-20 08:11AM  
Mar-06-20 10:18AM  
Mar-04-20 09:53AM  
Feb-28-20 11:45AM  
Feb-27-20 07:25PM  
04:05PM  
Feb-20-20 12:31PM  
Feb-13-20 08:54AM  
Feb-06-20 07:30AM  
Feb-04-20 04:23AM  
Jan-18-20 09:15AM  
Jan-07-20 04:05PM  
Dec-23-19 08:54AM  
Dec-12-19 01:43PM  
Dec-06-19 02:26PM  
Dec-02-19 04:14PM  
Nov-27-19 07:18AM  
Nov-11-19 05:25PM  
04:05PM  
Nov-05-19 08:03AM  
Nov-04-19 10:30AM  
07:00AM  
Oct-30-19 02:00PM  
Oct-28-19 11:01AM  
Oct-22-19 07:30AM  
Oct-14-19 08:16PM  
Oct-08-19 08:06AM  
Oct-07-19 04:15PM  
Sep-18-19 09:05AM  
Sep-13-19 05:54PM  
Sep-09-19 07:00AM  
Aug-30-19 10:31AM  
Aug-29-19 10:06AM  
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Voigtlander Christian B.Chief Operating OfficerFeb 18Option Exercise0.003,519010,949Feb 19 05:36 PM
Jain VivekChairman and CEOFeb 18Option Exercise0.008,044014,285Feb 19 05:31 PM
Woolson DanielVP, GM-Infusion CapitalFeb 18Option Exercise0.0080406,944Feb 19 05:27 PM
Sanzone Virginia RuthVP, General CounselFeb 18Option Exercise0.001,00502,502Feb 19 05:15 PM
SWINNEY ROBERT SDirectorFeb 02Option Exercise43.121,50064,68024,005Feb 02 05:01 PM
Jain VivekChairman and CEOJan 08Option Exercise58.7938,5912,268,765104,832Jan 08 05:11 PM
Jain VivekChairman and CEOJan 08Sale220.0038,5918,490,02066,241Jan 08 05:11 PM
Jain VivekChairman and CEOJan 07Option Exercise58.796,070356,85572,311Jan 08 05:11 PM
Jain VivekChairman and CEOJan 07Sale220.006,0701,335,40066,241Jan 08 05:11 PM
Jain VivekChairman and CEOJan 06Option Exercise58.7924,3391,430,89090,580Jan 08 05:11 PM
Jain VivekChairman and CEOJan 06Sale220.0024,3395,354,58066,241Jan 08 05:11 PM
Jain VivekChairman and CEOJan 04Option Exercise58.7911,500676,08577,741Jan 06 04:15 PM
Jain VivekChairman and CEOJan 04Sale212.3511,5002,442,01266,241Jan 06 04:15 PM
Jain VivekChairman and CEODec 04Option Exercise58.799,200540,86875,441Dec 07 06:06 PM
Jain VivekChairman and CEODec 04Sale195.009,2001,794,00066,241Dec 07 06:06 PM
Jain VivekChairman and CEODec 03Option Exercise58.792,300135,21768,541Dec 07 06:06 PM
Jain VivekChairman and CEODec 03Sale195.002,300448,50066,241Dec 07 06:06 PM
LOPEZ GEORGE ADirectorNov 12Sale194.8017,0003,311,546240,314Nov 12 05:27 PM
LOPEZ GEORGE ADirectorNov 11Sale194.1023,0004,464,324240,314Nov 12 05:27 PM
Jain VivekChairman and CEONov 06Option Exercise58.7911,500676,08577,741Nov 10 05:09 PM
Jain VivekChairman and CEONov 06Sale195.0011,5002,242,50066,241Nov 10 05:09 PM
SWINNEY ROBERT SDirectorOct 16Option Exercise36.601,50054,90022,782Oct 16 05:05 PM
SWINNEY ROBERT SDirectorOct 16Sale202.2227756,01522,505Oct 16 05:05 PM
Jain VivekChairman and CEOOct 09Option Exercise58.7911,500676,08577,741Oct 13 04:04 PM
Jain VivekChairman and CEOOct 09Sale195.0011,5002,242,50066,241Oct 13 04:04 PM
McGrody Kevin JChief Accounting OfficerSep 01Option Exercise0.0057202,632Sep 02 12:18 PM
Jain VivekChairman and CEOSep 01Option Exercise58.7911,500676,08577,681Sep 03 04:45 PM
Jain VivekChairman and CEOSep 01Sale197.1711,5002,267,48766,181Sep 03 04:45 PM
Jain VivekChairman and CEOAug 27Option Exercise58.7911,500676,08577,681Aug 28 05:27 PM
Jain VivekChairman and CEOAug 27Sale195.0011,5002,242,50066,181Aug 28 05:27 PM
Bonnell Brian MichaelChief Financial OfficerAug 14Option Exercise0.001,20801,553Aug 14 06:11 PM
FINNEY ELISHA WDirectorAug 13Sale190.00790150,1001,483Aug 13 05:18 PM
SWINNEY ROBERT SDirectorJul 16Option Exercise37.001,50055,50021,582Jul 16 05:40 PM
SWINNEY ROBERT SDirectorJul 16Sale188.4630056,53821,282Jul 16 05:40 PM
LOPEZ GEORGE ADirectorJun 09Sale194.898,8001,715,010339,764Jun 10 06:24 PM
LOPEZ GEORGE ADirectorJun 08Sale203.111,200243,736339,764Jun 10 06:24 PM
LOPEZ GEORGE ADirectorJun 03Sale199.009,3311,856,869339,764Jun 04 07:38 PM
LOPEZ GEORGE ADirectorJun 02Sale200.294,118824,796339,764Jun 04 07:38 PM
Jain VivekChairman and CEOJun 01Sale203.8715,0003,058,05266,211Jun 03 04:59 PM
LOPEZ GEORGE ADirectorMay 28Sale197.3716,5513,266,738329,651Jun 01 04:51 PM
FINNEY ELISHA WDirectorMay 13Option Exercise0.0037802,273May 14 03:50 PM
Abbey DonaldDirectorMay 13Option Exercise0.003780693May 14 12:54 PM
Hoffmeister David FDirectorMay 13Option Exercise0.003780693May 14 03:59 PM
Greenberg David C.DirectorMay 13Option Exercise0.0037802,703May 14 12:25 PM
SWINNEY ROBERT SDirectorMay 13Option Exercise0.00378020,082May 14 12:18 PM
SWINNEY ROBERT SDirectorApr 06Sale207.151,500310,72519,704Apr 06 05:13 PM
Woolson DanielVP, GM-Infusion CapitalMar 27Option Exercise0.0024306,247Mar 30 11:43 AM
Voigtlander Christian B.Chief Operating OfficerMar 27Option Exercise0.0059308,154Mar 30 11:39 AM
Sanzone Virginia RuthVP, General CounselMar 27Option Exercise0.0059301,809Mar 30 11:35 AM
Jain VivekChairman and CEOMar 27Option Exercise0.001,933082,290Mar 30 11:31 AM
McGrody Kevin JChief Accounting OfficerMar 27Option Exercise0.0064702,400Mar 30 11:27 AM
Voigtlander Christian B.Chief Operating OfficerMar 06Option Exercise0.002,61608,320Mar 10 03:46 PM
Woolson DanielVP, GM-Infusion CapitalMar 06Option Exercise0.001,44306,643Mar 10 03:34 PM
Jain VivekChairman and CEOMar 06Option Exercise0.004,124081,116Mar 10 03:26 PM
Sanzone Virginia RuthVP, General CounselMar 06Option Exercise0.001,44301,975Mar 10 03:21 PM
McGrody Kevin JChief Accounting OfficerMar 06Option Exercise0.001,68002,284Mar 10 03:15 PM
Bonnell Brian MichaelChief Financial OfficerMar 06Option Exercise0.007220722Mar 10 02:59 PM